United BioSource Corporation Opens New Office in Germany
BETHESDA, MD (June 15, 2010) United BioSource Corporation (UBC) today announced the launch of a new office in Lörrach, Germany, further expanding the company’s clinical research and medical affairs capabilities in Europe. The Lörrach office is located near Basel, Switzerland and is the 10th UBC office to open in Europe, adding to facilities in the United Kingdom, Switzerland, Ukraine, Spain, Sweden, Hungary and the Czech Republic.
The new location builds on UBC’s global development and support capabilities for biopharmaceuticals, and other medical products. The new office will be led by Ms. Hazel Wohlfahrt, Executive Director of Clinical Services, Europe. Ms. Wohlfart has coordinated and led large international clinical studies and registries, covering all countries in Europe and is a recognized leader in German speaking countries.
“Our new office brings together clinical research experts in project and site management & monitoring with many decades of combined experience designing and executing successful product development programs,” said Sean Hart, UBC’s General Manager for Clinical Services. “Our operational delivery capabilities, coupled with our growing site support team, who have a deep familiarity with the languages and populations in this region, provides our clients the strongest local support to develop and commercialize products in these important markets.”
The project and site management teams based in Lörrach have experience in a broad range of therapeutic areas. Key capabilities include, study planning, study monitoring, biometrics and, execution of Phase II-IV clinical studies, registries and observational studies. The project and site management team members are all bi-lingual in German and English and collectively, they have experience in the areas of neurology, oncology, epidemiology, cardiology, hematology and pediatrics. Leading the biometrics team is Dr. Klaus Freivogel, who has experience in the planning, execution of Phase II-IV clinical studies throughout Western Europe, Africa, and North America.
About United BioSource Corporation
United BioSource Corporation (UBC) is a global scientific and medical affairs organization that partners with life science companies to develop and commercialize biopharmaceuticals, medical devices, and other health care products. We help deliver authoritative, real-world evidence to characterize product effectiveness, address safety risk, and demonstrate value. UBC brings together recognized scientific and industry experts, research operations professionals, and new technologies to provide innovative solutions across the product lifecycle. The company is headquartered in Bethesda, Maryland, with offices in North and South America, Europe and Asia. For more information about UBC, visit www.unitedbiosource.com.